Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
for Malignant Peripheral Nerve Sheath Tumor (MPNST)
1 location in Washington D.C.
Sponsor: AeRang Kim
Sex: All·Age: 18+
Code: NCT06735820·Phase 1, Phase 2·Not Yet Recruiting